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Abstract. 
 
A more complete picture of the molecules 
that are critical for the organization of membrane com-
partments is beginning to emerge through the charac-
terization of proteins in the vesicle-associated mem-
brane protein (also called synaptobrevin) family of 
membrane trafﬁcking proteins. To better understand 
 
the mechanisms of membrane trafﬁcking within the 
endocytic pathway, we generated a series of mono-
clonal and polyclonal antibodies against the cytoplas-
mic domain of vesicle-associated membrane protein 7 
(VAMP-7). The antibodies recognize a 25-kD mem-
brane-associated protein in multiple tissues and cell 
lines. Immunohistochemical analysis reveals colocaliza-
tion with a marker of late endosomes and lysosomes, 
lysosome-associated membrane protein 1 (LAMP-1), 
but not with other membrane markers, including p115 
and transferrin receptor. Treatment with nocodozole or 
brefeldin A does not disrupt the colocalization of 
VAMP-7 and LAMP-1. Immunoelectron microscopy 
analysis shows that VAMP-7 is most concentrated in 
the 
 
trans
 
-Golgi network region of the cell as well as late 
endosomes and transport vesicles that do not contain 
the mannose-6 phosphate receptor. In streptolysin-
O–permeabilized cells, antibodies against VAMP-7 in-
hibit the breakdown of epidermal growth factor but not 
the recycling of transferrin. These data are consistent 
with a role for VAMP-7 in the vesicular transport of 
proteins from the early endosome to the lysosome.
Key words: VAMP-7 • SNARE • endosome • lyso-
some • membrane trafﬁcking
 
E
 
UCARYOTIC
 
 cells compartmentalize biological func-
tions in a series of membrane-bound organelles.
One critical and highly regulated trafficking deci-
sion made by all cells is whether to degrade a protein or
transport it to a site of storage or function. The major deg-
radative compartment in cells is the lysosome, an or-
ganelle filled with an array of enzymes that hydrolyze bio-
logical molecules to component metabolites (Kornfeld
and Mellman, 1989). Most trafficking into the lysosome is
thought to originate from the highly dynamic early endo-
some (EE),
 
1
 
 or sorting endosome (Mellman, 1996). The
EE contains morphologically distinct domains, including a
vacuolar domain that is continuous with a network of tu-
bular extensions. In addition, an extended network of en-
dosomal tubules and vesicles is often found dispersed
throughout the cytoplasm (Mellman, 1996).
Membrane proteins such as the transferrin receptor
(TfR) are internalized from the cell surface through the
formation of clathrin-coated vesicles (Pearse, 1987; Pearse
and Robinson, 1990). Following endocytosis, proteins are
transferred to the EE, where molecules that will recycle
back to the plasma membrane accumulate within the tubu-
lar domain of the compartment (Mellman, 1996; Robinson
et al., 1996). From these tubular extensions of the EE,
molecules can be rapidly trafficked back to the cell surface
or to a centrally localized compartment known as the recy-
cling endosome (RE) (Gruenberg and Maxfield, 1995).
These REs, also known as the 
 
peri
 
-Golgi recycling com-
partment, have the ability to further sort proteins for vari-
ous destinations within the cell (Hopkins, 1983; Hopkins
and Trowbridge, 1983). Although some molecular mark-
ers appear to differentiate between EEs and REs, a dis-
tinct boundary between them is obscured due to the in-
tricate network of tubules and vesicles that comprise
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1. 
 
Abbreviations used in this paper:
 
 aa, amino acid(s); BFA, brefeldin A;
EE, early endosome; GST, glutathione 
 
S
 
-transferase; LAMP-1, lysosome-
associated membrane protein 1; LE, late endosome; MPR, mannose-6
phosphate receptor; NEM, 
 
N
 
-ethylmaleimide; NSF, NEM-sensitive fac-
tor; PNS, postnuclear supernatant; RE, recycling endosome; SLO, strep-
tolysin-O; SNAP, soluble NSF attachment protein; SNAP-25, synaptoso-
mal-associated protein of 25 kD; SNARE, SNAP receptor; Tf, transferrin;
TfR, Tf receptor; VAMP, vesicle-associated membrane protein. 
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the organelles (Hopkins, 1983; Hopkins and Trowbridge,
1983; Yamashiro et al., 1984; Gosh et al., 1994). Following
endocytosis and transfer to the EE, proteins that are des-
tined for degradation, such as EGF, remain largely within
the vacuolar domain of the endosome (Hopkins et al.,
1990). The vacuolar domain then either matures directly
or shuttles proteins via vesicular trafficking to late endo-
somes (LEs), which further mature into lysosomes (Futter
et al., 1996). Although the mechanisms of vesicle forma-
tion, sorting, and membrane fusion within the endosomal
network are not understood, a large number of cargo pro-
teins with well-characterized trafficking pathways are known
and can be used to study the process.
The most intensively studied vesicle trafficking proteins
are the low molecular weight GTPases, the Rabs (Novick
and Zerial, 1997), and membrane fusion proteins of the
vesicle-associated membrane protein (VAMP), syntaxin
and synaptosomal-associated protein of 25 kD (SNAP-25)
families, the soluble 
 
N
 
-ethylmaleimide–sensitive factor at-
tachment protein (SNAP) receptors (SNAREs) (Bennett
and Scheller, 1994; Jahn and Südhof, 1994; Rothman,
1994). Approximately 40 Rabs are known to discretely lo-
calize throughout the secretory pathway. Rabs 4 and 5
(Bucci et al., 1992; Daro et al., 1996) are associated with
the EE, Rab 11 (Ulrich et al., 1996) is believed to be spe-
cifically localized to the RE, and Rabs 7 and 9 (Chavrier et
al., 1990; Lombardi et al., 1993) are associated with LEs.
Rab proteins are likely to be important in early steps of
the docking process by acting through a diverse set of ef-
fector proteins. Many different SNARE proteins have also
been characterized. Formation of a very stable four-
stranded helical bundle, comprised of SNAREs from op-
posing membranes, is thought to be the biochemical event
that drives membrane fusion, although this issue is still of
some debate (Lin and Scheller, 1997; Poirier et al., 1998;
Weber et al., 1998). The soluble factors 
 
a
 
SNAP and 
 
N
 
-eth-
ylmaleimide (NEM)-sensitive factor (NSF) play an impor-
tant role as molecular chaperones to dissociate SNARE
protein complexes so that they are able to independently
recycle and so that SNAREs can reform complexes to
drive another round of membrane fusion (Sollner et al.,
1993; Mayer et al., 1996). Although only three members of
the SNAP-25 family (SNAP-23, -25, and -29) (Oyler et al.,
1989; Bennett et al., 1993; Ravichandran et al., 1996; Steeg-
maier et al., 1998) are known, many more members of the
VAMP and syntaxin families have been characterized.
The SNAREs, particularly VAMPs and syntaxins, are
specifically localized throughout the mammalian secre-
tory pathway, including the ER, the Golgi apparatus, the
TGN, the EE, synaptic vesicles, and the plasma membrane
(Hay and Scheller, 1997). Thus, while the localization of
SNAREs to distinct membrane compartments is consis-
tent with a function in regulating the specificity of mem-
brane trafficking, different family members form com-
plexes indiscriminately in vitro, leaving open the question
of their roles in determining the fidelity of membrane fu-
sion events (Yang et al., 1999).
Few SNAREs have been shown to specifically function
within the endosomal pathway, and a subset of VAMPs
and syntaxins do seem to localize to specific domains
within these compartments. VAMP-3, VAMP-8, syntaxin
7, and syntaxin 13 are thought to localize to endosomes
(Link et al., 1993; Wang et al., 1997; Advani et al., 1998;
Wong et al., 1998). Syntaxin 13 is found in tubular EEs and
REs where it colocalizes with TfR. Consistent with this lo-
calization, functional studies support a role for syntaxin 13
in transferrin (Tf) recycling in permeabilized PC12 cells.
In neurons, syntaxin 13 forms SNARE complexes, likely
with SNAP-25 and VAMP-2/3, and these complexes are
dissociated by 
 
a
 
SNAP and NSF (Prekeris et al., 1998).
If each distinct trafficking step requires specific SNAREs
or a particular subset of SNAREs, many other VAMPs and
syntaxins are likely to function within the endosomal net-
work. In particular, little is known about the SNARE pro-
teins responsible for trafficking from EEs to LEs on to the
lysosome. To better understand membrane trafficking
within the endosomal pathway, we have characterized the
localization and function of VAMP-7, also known as TI-
VAMP (Galli et al., 1998). This toxin-resistant SNARE is
likely to function along the pathway from EEs to LEs or
from LEs to lysosomes.
 
Materials and Methods
 
Antibodies
 
Full-length recombinant VAMP-7 protein lacking its COOH-terminal hy-
drophobic domain was used to immunize both a rabbit and a mouse. Af-
finity-purified polyclonal antibodies against VAMP-7 were then prepared
from rabbit antisera as described previously (Bock et al., 1996).
mAbs against VAMP-7 were obtained from the corresponding hybrid-
oma cell lines produced by fusion of NS-1 mouse myeloma cells with
spleen cells from an immunized BALB/c mouse as described previously
(Bock et al., 1997). The mAbs were isotyped using an ELISA system
(Boehringer Mannheim). Ascites fluid was prepared by Joseph Beirao
(Josman Laboratories, Napa Valley, CA). The mAb epitopes were
mapped by Western blotting against three glutathione 
 
S
 
-transferase
(GST)–fusion protein constructs consisting of various portions of the cyto-
plasmic domain of VAMP-7: 1–23 amino acids (aa), 1–123 aa, or 1–182 aa.
Rat anti–lysosome-associated membrane protein 1 (LAMP-1) mAbs
were purchased from PharMingen. Mouse anti-TfR mAbs were purchased
from Zymed Laboratories, Inc. Mouse anti-p115 antibodies have been de-
scribed previously (Waters et al., 1992). Texas red–labeled anti–rabbit
IgG, FITC-labeled anti–mouse IgG, and FITC-labeled anti–rat IgG anti-
bodies were obtained from Jackson ImmunoResearch Laboratories. Rab-
bit antibody lym3 against the cytosolic tail of lgp120 was kindly provided
by Dr. I. Mellman (Yale University, New Haven, CT). Rabbit antibody
MSCI against the cytosolic part of the cation-dependent mannose 6-phos-
phate receptor (CD-MPR) was a gift from Dr. A. Hille (Georg-August
University, Gottingen, Germany). In some single-labeled sections, a swine
anti–rabbit IgG (SWAR) antibody was used (Nordic Immunological Lab-
oratories) after the incubation step with VAMP-7 antibody to enhance the
density of immunostaining.
Western blotting was performed using ECL (Amersham Pharmacia
Biotech).
 
Immunofluorescence Microscopy
 
Indirect immunofluorescence localization was performed on NIH-3T3
cells as described previously (Hay et al., 1996). Antisera were used at the
following dilutions: anti–VAMP-7 polyclonal antibody at 2 
 
m
 
g/ml; anti–
LAMP-1 mAb at 0.05 
 
m
 
g/ml; anti-TfR mAb at 1 
 
m
 
g/ml; and Texas red–
labeled anti–rabbit IgG, FITC-labeled anti–mouse IgG, and FITC-labeled
anti–rat IgG antibodies at 7.5 
 
m
 
g/ml.
 
Immunogold Labeling of Ultrathin Cryosections
 
PC12 cells were prepared for ultrathin cryosections, and (double)-immu-
nogold labeling according to the protein A–gold method was carried out
as described previously (Slot et al., 1991). For a quantitative analysis of
the subcellular distribution of VAMP-7, well-preserved areas of two dif- 
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ferent grids single-immunogold labeled for VAMP-7 were selected, and at
a magnification of 25,000 in the electron microscope, all gold particles
were counted and subscribed to the compartment over which they were
located. The definition of the distinct compartments was based on their
morphology. The Golgi complex was recognized by its characteristic ap-
pearance of stacked cisternae, and the array of tubulovesicular mem-
branes that were located at the 
 
trans
 
-side of the Golgi was considered the
TGN. EEs were defined as elongated, sometimes curved, electron-lucent
vacuoles with few internal vesicles. LEs were defined as globular shaped
compartments with numerous internal vesicles. Connected to or in close
association with these endosomal vacuoles, many tubulovesicular mem-
brane profiles were present that we indicated as endosome-associated ves-
icles. Electron-dense compartments without or with degraded internal
membranes were categorized as lysosomes. These definitions are based on
the description of the endocytic compartments in a variety of cell types
(Griffiths et al., 1989; Klumperman et al., 1993; Kleijmeer et al., 1997). In
PC12 cells, the compartments that by these definitions were defined as
LEs and lysosomes stained positive for the LE/lysosomal marker protein
lgp120 (see Fig. 6), whereas TfR localized to the compartments defined as
EEs (data not shown). Finally, when the endocytic tracer BSA-gold was
added to PC12 cells, it appeared in EEs, LEs, and lysosomes after 1-, 10-,
and 60-min uptakes, respectively (Klumperman, J., manuscript in prepara-
tion).
 
Membrane Extraction Studies
 
Membrane extraction studies of VAMP-7 were carried out on NIH-3T3
cells as described previously (Hay et al., 1996; Advani et al., 1998).
 
EGF and Tf Trafficking in Permeabilized HeLa Cells
 
To measure EGF and Tf trafficking, we adopted with slight modifications
the streptolysin-O (SLO)-permeabilized cell system (Prekeris et al., 1998).
In brief, HeLa cells were loaded with either 
 
125
 
I-EGF or 
 
125
 
I-Tf at 18
 
8
 
C for
1 h and then extensively washed to remove unbound EGF/Tf. Cells were
then permeabilized with SLO as described previously (Prekeris et al.,
1998). Where indicated, cells were incubated at 37
 
8
 
C for varying periods
of time. To remove cytosol, cells were incubated for 1 h on ice with KTM
buffer (115 mM potassium acetate, 25 mM Hepes, pH 7.4, 2.5 mM magne-
sium acetate, and 1 mg/ml BSA) and then washed extensively with ice-
cold KTM buffer. Under these conditions, 
 
z
 
95% of the cytosol can be re-
moved from the permeabilized cells (Prekeris et al., 1998). Permeabilized
cells were then resuspended in 0.5 ml of KTM buffer with or without 3
mg/ml rat brain cytosol. In all cases, KTM buffer was supplemented with
0.5 mM ATP and an ATP regeneration system (80 mM creatine phos-
phate, 9 U/ml creatine kinase). EGF/Tf trafficking was induced by incu-
bating samples at 37
 
8
 
C for specified amounts of time. Where indicated,
permeabilized HeLa cells were preincubated for 1 h with 100 
 
m
 
g/ml IgG,
affinity-purified rabbit polyclonal anti–VAMP-7 antibodies, mouse mono-
clonal 22G2 and 1D9 anti–VAMP-7 antibodies, or anti–syntaxin 6 anti-
bodies. Where indicated, affinity-purified rabbit polyclonal anti–VAMP-7
antibody was preincubated with 150 
 
m
 
g/ml GST–VAMP-7 or GST. After
incubation at 37
 
8
 
C, KTM buffer was removed and cells were solubilized
with 0.5 ml KTM buffer containing 2% Triton X-100 to determine the
amount of EGF/Tf remaining in the cell. The removed buffer represents
released EGF/Tf. To determine the amount of degraded EGF, the re-
moved buffer was extracted with 10% TCA and the precipitate containing
recycled intact EGF (Futter et al., 1996) was sedimented by centrifugation
at 10,000 
 
g
 
 for 15 min. Remaining soluble 
 
125
 
I represents degraded EGF
(Futter et al., 1996). Similar TCA extraction of the buffer containing re-
leased 
 
125
 
I-Tf resulted in the complete sedimentation of all 
 
125
 
I (data not
shown), in agreement with the data that Tf does not get targeted to the ly-
sosomes for degradation. The amounts of 
 
125
 
I-EGF degraded and 
 
125
 
I-Tf
recycled were determined by scintillation counting and expressed as the
percentage of total EGF/Tf (the sum of released and intracellular Tf/EGF
for each sample).
The rat brain cytosol for EGF degradation and Tf recycling assays was
prepared as described previously (Prekeris et al., 1998). In brief, fresh rat
brains were homogenized in 25 mM Hepes, pH 7.4, containing 115 mM
potassium acetate, 2.5 mM magnesium acetate, 0.1 mM EGTA, 2 mM
DTT, 4 
 
m
 
g/ml aprotinin, and 0.8 
 
m
 
g/ml pepstatin. This homogenate was
then centrifuged at 10,000 
 
g
 
 for 20 min, followed by 100,000 
 
g
 
 for 45 min.
Cytosol was then flash-frozen in liquid nitrogen and stored at 
 
2
 
80
 
8
 
C. The
protein concentration was determined by the Bradford assay according to
the manufacturer’s instructions (BioRad). Where indicated, cytosol was
pretreated with 0.2 mM NEM for 30 min on ice.
 
Results
 
VAMP-7 Is Broadly Expressed
 
To further investigate the function of VAMP-7, we gener-
ated one rabbit polyclonal and five mouse mAbs using the
full-length VAMP-7 protein lacking its COOH-terminal
hydrophobic region as the immunogen. All six antibodies
recognized a single band of the expected molecular mass,
25 kD, on Western blots of rat kidney postnuclear super-
natant (PNS) (Fig. 1 A). To define more precisely the re-
gion of VAMP-7 recognized by the mAbs, each antibody
was tested for binding to three different GST–fusion pro-
tein constructs of VAMP-7 (Fig. 1 B). mAbs 8B7 and 23B8
bind to aa 23–123. 1D9, 22G2, and 24C3 bind in the region
encompassed by aa 123–182, the approximate region of
the helical domain important in forming the core fusion
complex. The rabbit polyclonal antibody used in these
studies recognizes epitopes in both these domains.
A previously reported Northern blot analysis indicates
that VAMP-7 mRNA is present in brain, kidney, spleen,
thymus, and liver while no RNA was detected in heart
(Advani et al., 1998). To analyze the protein expression
pattern of VAMP-7, affinity-purified polyclonal antibod-
Figure 1. Polyclonal antibodies and mAbs specifically recognize
VAMP-7. (A) 20 mg of PNS from rat kidney was probed for
VAMP-7 with an affinity-purified polyclonal and five different
mAbs. A 25-kD band is recognized by all antibodies. (B) The do-
main of VAMP-7 recognized by the mAbs was mapped. The
transmembrane (TM) region corresponds to the predicted mem-
brane anchor. The coil domain is recognized by three antibodies
and a more NH2-terminal domain by two antibodies. 
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ies were used to detect VAMP-7 protein in several tissues.
In agreement with the Northern blot results, VAMP-7
protein was expressed in all tissues tested except heart and
muscle (Fig. 2 A). In liver, in addition to the 25-kD band,
an additional immunoreactive species of 
 
z
 
27 kD was de-
tected. This band could represent either a posttransla-
tional modification, an alternatively spliced isoform, or
a cross-reactive protein distinct from VAMP-7 that is
present only in liver. We used several cell lines for further
investigation of VAMP-7 function and localization, includ-
ing PC12, NIH-3T3, and HeLa cells. The antibodies detect
a single band of 25 kD in these cell lines as exemplified by
the pattern seen in PC12 cells (Fig. 2 A). Based on the
broad mRNA and protein distribution of VAMP-7, it ap-
pears that VAMP-7 is involved in a trafficking pathway
that is common to most cell types.
VAMP-7 contains a hydrophobic COOH-terminal se-
quence thought to be a membrane anchor (Advani et al.,
1998). To determine if VAMP-7 behaves as a membrane
protein, NIH-3T3 cells were homogenized and the PNS
was fractionated into cytosolic and membrane fractions.
The membranes were then extracted under various condi-
tions and fractionated into supernatant and pellet frac-
tions. Even when extracted with 1.5 M NaCl or pH 11.0,
VAMP-7 was recovered in the pellet fraction. Only when
the membranes were solubilized with 2% Triton X-100 did
 
the protein redistribute to the supernatant, consistent with
VAMP-7 being an integral membrane protein (Fig. 2 B).
 
VAMP-7 Localizes to Endosomes
 
Understanding the localization of a SNARE within a cell
is critical information for understanding the membrane
trafficking step mediated by that protein. We reported
previously that epitope-tagged, full-length VAMP-7 dis-
played a perinuclear punctate staining pattern, and showed
significant overlap with the late endosomal/lysosomal pro-
tein lgp120 (Advani et al., 1998). To ascertain the localiza-
tion of endogenous VAMP-7, we stained NIH-3T3 cells
with anti–VAMP-7 mAb 1D9, anti–VAMP-7 mAb 24C3,
and anti–VAMP-7 affinity-purified polyclonal antibodies.
In double labeling experiments, each mAb exhibited a
staining pattern identical to that of the polyclonal anti-
body, and addition of VAMP-7 cytoplasmic domain blocked
the immunostaining. These control experiments demon-
strate that the localization is due to specific recognition of
VAMP-7 (data not shown).
To begin a more detailed study of the intracellular local-
ization of endogenous VAMP-7, we compared its immu-
nostaining pattern with those of well-characterized mark-
ers of Golgi, endosomal, and lysosomal compartments.
VAMP-7  showed little if any colocalization with TfR, a
marker of EEs, and p115, a marker of the Golgi (Fig. 3,
D–I). However, endogenous VAMP-7, like the transfected
protein, is localized in a pattern that overlapped consider-
ably with LAMP-1, a marker of LEs and lysosomes (Fig. 3,
A–C). In NIH-3T3 cells, EEs, LEs, and lysosomes are all
clustered around the Golgi stacks making it difficult, at the
level of light microscopy, to resolve these organelles in this
region of the cell. However, it is possible to differentiate
these membrane compartments in the periphery of the cells
where the organelles are more dispersed. In the cell
periphery, the precise colocalization of VAMP-7 and
LAMP-1 in many puncta becomes most evident. The in-
tensity of VAMP-7 and LAMP-1 staining for the indi-
vidual puncta varies: some show more intense VAMP-7
immunoreactivity, whereas others show more intense LAMP-1
immunoreactivity.
The effect of membrane trafficking perturbants such as
nocodozole and brefeldin A (BFA) on vesicle trafficking
proteins can unveil features of their native localization and
cycling patterns. The microtubule-depolymerizing agent,
nocodozole, has been shown to cause vesiculation and dis-
persal of both Golgi cisternae and early endosomal com-
partments (Turner and Tartakoff, 1989). Treatment of
NIH-3T3 cells with 10 
 
m
 
M nocodozole did cause TfR-posi-
tive EEs to scatter throughout the cytoplasm (Fig. 4, D–F).
However, both LAMP-1–positive and VAMP-7–positive
organelles were relatively unaffected by nocodozole treat-
ment (Fig. 4, A–C).
BFA treatment results in a block in anterograde ER-to-
Golgi traffic, and due to the fact that the drug does not dis-
rupt retrograde trafficking, Golgi proteins redistribute to
the ER (Robinson and Kreis, 1992). Additionally, in cer-
tain cells, BFA treatment results in the collapse of the
TGN and certain classes of endosomes onto the microtu-
bule-organizing center (Lippincott-Schwartz et al., 1991;
Reaves and Banting, 1992). Again, BFA seems to have lit-
Figure 2. VAMP-7 is broadly expressed and associates with
membranes. (A) Seven tissues and PC12 cells were probed with
the polyclonal antibody for VAMP-7 expression as described in
the text and Materials and Methods. 20 mg of PNS was used for
each tissue. (B) PNS was fractionated into cytosolic and mem-
brane fractions. The membrane pellet was extracted with 1.5 M
NaCl, pH 11.0, or 2% Triton X-100 and centrifuged into superna-
tant (S) or pellet (P) fractions. 
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tle effect on the distribution of organelles containing ei-
ther VAMP-7 or LAMP-1 (Fig. 4, G–I). In contrast, TfR
staining collapses into the microtubule-organizing center
(Fig. 4, J–L). These results are consistent with the localiza-
tion of VAMP-7 on LEs and/or lysosomes.
 
VAMP-7 Is Enriched in the TGN Region and LEs
 
To gain a more precise understanding of the subcellular
distribution of VAMP-7, ultrathin cryosections were
prepared from PC12 cells and immunogold labeled with
affinity-purified polyclonal anti–VAMP-7 antibody. The
amount of labeling on various membranes was quantified
by defining the distribution of 372 gold particles. A discus-
sion of the criteria used for morphological definition of the
membrane compartments is provided in Materials and
Methods. Approximately 8% of the labeling was found to
be within the Golgi stacks, whereas 30% was found within
the TGN region (Fig. 5 A). The plasma membrane was vir-
tually devoid of label. Previously, we localized two other
SNARE proteins, syntaxin 6 and VAMP-4, in the TGN re-
gion of PC12 cells, and found that these SNAREs were in-
corporated into clathrin-coated vesicles and immature
secretory granules (Bock et al., 1997; Steegmaier et al.,
1999). Unlike these SNAREs, VAMP-7 did not signifi-
cantly label clathrin-coated vesicles or immature secretory
granules in the TGN. Within the endosomal compart-
ments, 5% of the VAMP-7–representing gold particles
were found on EEs, 22% on LEs, and 30% on LE-associ-
ated vesicles. 5% of the gold particles were found on lyso-
somes (Fig. 5, B and C). On LEs, VAMP-7 colocalized
with lgp120 (Fig. 6 B). 200 endocytic compartments were
categorized into EEs, LEs, or lysosomes to quantify the
number of these organelles in PC12 cells. According to the
criteria we used to define these organelles (see Materials
and Methods), 19% of the structures were EEs, 25% LEs,
and 57% lysosomes. Thus, we conclude that VAMP-7 is
enriched in the LE compartment. We further studied the
sublocalization of VAMP-7 within the endosomes. Within
EEs (89 particles), VAMP-7 was found at the limiting
membrane of the vacuole (39%) and on associated vesi-
cles (60%), whereas there was virtually no labeling of in-
ternal vesicles (1%). Within the LE compartment (195
particles), 44% of the gold particles were found on the
vacuole membrane, 41% on associated vesicles, and 15%
on internal vesicles.
Vesicles that label for VAMP-7 do not generally contain
the MPR, suggesting VAMP-7 functions in a trafficking
pathway distinct from TGN-to-endosome transport (Fig. 6
A). In addition, the vesicles that contain VAMP-7 were
Figure 3. VAMP-7 partially
colocalizes with an LE and
lysosomal marker in NIH-
3T3 cells. VAMP-7 immu-
noreactivity (Texas red; A,
D, and G) is compared with
immunofluorescence (FITC)
of LAMP-1 (B), p115 (E), or
TfR (H). C, F, and I are the
merged images. Arrowheads
in A–C point to puncta that
are immunoreactive for both
VAMP-7 and LAMP-1. Bar,
10 mm. 
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generally large and less electron-dense than the typical
MPR-carrying vesicles (Fig. 6 A) (Klumperman et al.,
1993). The light and EM immunohistochemical studies
suggest that VAMP-7 plays a role in transport within the
endosomal pathway, perhaps from EEs to LEs or from
LEs to the lysosome. Although we are not able to pre-
cisely define the compartment labeled within the TGN,
the morphological data are also consistent with a role in
TGN trafficking.
 
VAMP-7 Functions in EE-to-Lysosome Trafficking
 
To investigate the role of VAMP-7 in Tf recycling and
EGF breakdown, we use a modified SLO-permeabilized
HeLa cell system (Prekeris et al., 1998). HeLa cells are in-
cubated for 1 h at 18
 
8
 
C with either 
 
125
 
I-EGF or 
 
125
 
I-Tf and
then washed to remove the unbound ligand. In intact cells,
recycling of TfR to the plasma membrane results in the re-
lease of Tf, a process that occurs over a period of 
 
z
 
80 min
(Fig. 7 A). Similarly, 
 
z
 
10% of the EGF is rapidly released
from cells and recovered as intact protein. The level of re-
leased, intact EGF plateaus at 
 
z
 
20 min. Degraded EGF,
defined as EGF that is not precipitated by TCA, begins to
increase after 
 
z
 
40 min and continues out to 120 min when
we ended the measurements. We further studied the re-
lease of intact and degraded EGF in SLO-permeabilized
cells (Fig. 7 B). Release of the two forms of EGF occurs
similarly in SLO-permeabilized cells as in intact cells, in-
Figure 4.  Distribution of
VAMP-7 immunoreactivity
in nocodozole- and BFA-
treated NIH-3T3 cells. (A–F)
Nocodozole-treated cells
stained for VAMP-7 (A and
D), LAMP-1 (B), or TfR
(E). (G–L) BFA-treated
cells stained for VAMP-7 (G
and J), LAMP-1 (H), or TfR
(K). Bar, 10 mm. 
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creasing to 45% of the total EGF released in degraded
form after 180 min (Fig. 7 B). The remainder of the EGF is
still present within the cell, suggesting that longer chase
periods would be required for its breakdown.
The cellular processes required for recycling of Tf and
breakdown of EGF are retained when cells are permeabi-
lized with SLO. We assayed effects of various antibodies
on the trafficking of the two ligands 2 h after incubation at
37
 
8
 
C. In the absence of cytosol or in the presence of NEM,
EGF degradation is largely blocked (Fig. 8 A). Further-
more, addition of IgG or anti–syntaxin 6 mAb to the per-
meabilized cells has no effect on EGF breakdown. How-
ever, when anti–VAMP-7 mAbs (1D9 or 24C3) are added
to the permeabilized cells, a significant reduction in EGF
breakdown is observed. While the reduction is only 
 
z
 
25%,
it is statistically significant, reproducible, and not observed
with control antibodies (Fig. 8 A). Addition of anti–
VAMP-7 polyclonal antibodies to EGF-loaded, permeabi-
lized cells resulted in a similar inhibition of EGF break-
down. To further control for the specificity of the antibody
inhibition, we demonstrated that addition of VAMP-7
protein, but not GST, to the antibody reversed the inhibi-
tion of EGF degradation (Fig. 8 B). The inhibition of EGF
breakdown is dependent on the concentration of anti–
Figure 5. VAMP-7 is localized to the TGN, LEs, and transport vesicles. Ultrathin cryosections of PC12 cells immunogold-labeled (10
nm gold) for VAMP-7. In A and B, the signal for VAMP-7 was enhanced by using an intermediate swine anti–rabbit IgG antibody. (A)
Overview of the perinuclear area. VAMP-7 is present in the Golgi complex (indicated by G) and many of the tubulovesicular mem-
branes of the TGN. The open star indicates an immature secretory granule, as judged by the electron-dense cytosolic clathrin coat. The
filled stars indicate mature secretory granules. No significant label is found over these secretory compartments. (B) VAMP-7 is present
on the limiting membrane of an LE. (C) LE-associated vesicles. L, lysosome; M, mitochondrion. Bars, 200 nm. 
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VAMP-7 antibody used in the assay, further confirming
the specificity of the inhibition (Fig. 8 C). Since lysosomal
degradation of EGF is likely to depend on several traffick-
ing steps, we wondered if it would be possible to chase the
EGF past the point at which the anti–VAMP-7 antibodies
block. After EGF loading at 18
 
8
 
C, we incubated the cells
for 0, 10, 20, or 40 min before permeabilization. Increasing
the incubation time resulted in a progressive decrease in
the level of EGF breakdown (Fig. 8 D). These data sug-
gest that we are able to chase the EGF into a compart-
ment, past the EE, which no longer depends on VAMP-7
for further trafficking to the lysosome. Finally, we further
investigated the effect of anti–VAMP-7 antibodies on the
recycling of Tf; however, we did not observe any effects on
this process (Fig. 8 E). We interpret these data as demon-
strating that antibody binding to VAMP-7 inhibits interac-
tions with other proteins. Since inhibition of these protein
interactions blocks EGF breakdown, we suggest that
VAMP-7 is necessary for a vesicular trafficking step
needed for EGF breakdown.
 
Discussion
 
The formation of helical bundles of SNARE proteins from
opposite membranes likely drives intracellular membrane
fusion. The discovery of syntaxin 1A, a SNARE largely lo-
calized to the plasma membrane, and Sed5p (syntaxin 5 in
mammalian cells) (Hardwick and Pelham, 1992; Hay and
Scheller, 1997), a syntaxin isoform largely localized to the
 
cis
 
-Golgi complex and ER-Golgi intermediate compart-
ment, led to the idea that intracellular membrane traffick-
ing and membrane fusion will be mediated by sets of
SNARE proteins. Furthermore, if SNARE proteins pair
specifically, part of the specificity of membrane trafficking
may be mediated by the formation of specific sets of core
fusion complexes. These ideas have become known as the
SNARE hypothesis (Bennett et al., 1993; Sollner et al.,
1993). For this hypothesis to be correct, several criteria
must be met. First, there need to be enough SNARE pro-
teins so that specific SNAREs, or at least a specific combi-
nation of SNAREs, could direct each vesicular trafficking
Figure 6. VAMP-7 colocalizes with lgp120 in LEs and is present on
MPR-negative transport vesicles. PC12 cells double-immunogold–
labeled for (A) the CD-MPR (MPR, 10 nm gold) and VAMP-7 (15
nm gold), and (B) VAMP-7 (10 nm gold) and lgp120 (15 nm gold).
(A) The small arrowheads point to small-sized, electron-dense
transport vesicles that contain the MPR but not VAMP-7. VAMP-7
is found on larger vesicles (large arrowheads) with a less electron-
dense content (see also Fig. 5 C). (B) VAMP-7 colocalizes with
lgp120 to the limiting membrane of an LE. The arrow points to a
connection between a VAMP-7–positive vesicle that is in continu-
ity with the vacuolar region of the LE. G, Golgi complex; L, lyso-
some; M, mitochondrion. Bars, 200 nm. 
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step. In mammalian cells, there are in fact many different
SNARE proteins, and they do have specific patterns of lo-
calization within cells. For example, syntaxin 5, rsec22b,
rbet1, and membrin are important in antero- and/or retro-
grade trafficking between the ER and the 
 
cis
 
-Golgi appa-
ratus (Hay et al., 1998). In contrast, syntaxin 1A, VAMP-1,
SNAP-25, and their closely related homologues are re-
quired for exocytosis (Hay and Scheller, 1997).
In this report we define a function for VAMP-7. The
protein is localized to LEs, where our functional data sug-
gest that it mediates trafficking to the lysosomes. The his-
tochemical data are supported by both polyclonal and
multiple mAbs, which strengthens the contention that the
immunolocalization is specific. However, the EGF break-
Figure 7. HeLa cells recycle Tf and break down EGF. (A) 125I-
EGF or -Tf was loaded into cells and then chased into the super-
natant. Tf was recovered in a TCA-precipitable form with a half-
life of z20 min (open circles). EGF is recovered in two forms,
TCA precipitated or intact (open triangles) and non-TCA pre-
cipitated or degraded (filled circles). The intact form of EGF rap-
idly appears in the cell media while the degraded form begins to
appear after z40 min and continues to increase throughout the
120-min period. (B) Cells loaded with 125I-EGF were permeabi-
lized with SLO. 125I-EGF degradation was measured in the pres-
ence (open circles) and absence (filled circles) of cytosol. EGF
degradation proceeds with similar kinetics in permeabilized and
intact cells.
Figure 8. VAMP-7 antibodies block EGF breakdown. (A) NEM
treatment blocks the degradation of EGF, but addition of IgG or
anti–syntaxin 6 antibodies has no effect on the process. Addition
of anti–VAMP-7 antibodies partially blocks degradation of EGF.
Measurements were made three times and the standard deviation
is indicated. An F-test indicated that the effect observed with
anti–VAMP-7 antibodies was statistically significant compared
with control antibodies (P , 0.01). (B) Anti–VAMP-7 affinity-
purified polyclonal antibody also inhibits EGF breakdown. In-
cluding VAMP-7 protein but not GST reverses the inhibition of
EGF degradation produced by the anti–VAMP-7 polyclonal an-
tibody. VAMP-7 protein and GST alone have no effect in the as-
say. Measurements were made two times and the average is
plotted. (C) Increasing amounts of VAMP-7 polyclonal or mono-
clonal antibodies result in an increased inhibition of EGF break-
down. Maximum inhibition is achieved at a concentration of 100
mg/ml VAMP-7 antibodies. Filled circles indicate polyclonal anti-
bodies; open circles indicate mAbs. (D) EGF-loaded cells were
chased for varying amounts of time at 378C followed by SLO-per-
meabilization. Cells were then incubated with antibody and EGF
degradation measured as described above. (E) Tf recycling is also
reconstituted by addition of cytoplasm to SLO-permeabilized
cells. Whereas NEM inhibits the recycling, neither IgG nor anti–
VAMP-7 antibodies affect the process. 
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down monitored in our assay is only partially inhibited by
antibodies against VAMP-7. Complete inhibition of a
transport step has never been observed in these types of
assays. The partial inhibition may be explained in several
ways. The antibodies may have access to only some of the
active VAMP-7, or the antibody affinity may not be suffi-
cient to block all SNARE interactions effectively. The an-
tibodies used for the transport inhibition studies recognize
the coil domain of VAMP-7 involved in SNARE complex
formation. Although this is a domain of critical functional
importance, and therefore an excellent site for function-
blocking antibodies, the high stability of SNARE com-
plexes may be such that the antibody can be displaced
from VAMP-7 during complex formation. Alternatively,
only a portion of the EGF may travel to a degradative
compartment via a VAMP-7–mediated process. Since
VAMP-7 is not present on vesicles that contain the MPR,
we conclude that this SNARE is not likely to be involved
in trafficking of enzymes to the lysosome.
VAMP-7 that is present on the internal vesicles of LEs
is likely to be degraded. This may partially explain why
only low levels of VAMP-7 are found at steady state in ly-
sosomes. In addition, we assign a significant amount of the
VAMP-7 immunoreactivity to the TGN although we have
not defined the subregion of the TGN that is immunoreac-
tive for VAMP-7. The morphological definition of the
TGN may include vesicles or tubules that are more appro-
priately considered part of the endosomal system. Since
nocodozole and BFA do not affect the localization of
VAMP-7, VAMP-7–positive organelles in the TGN region
are more likely to be related to endosomal compartments.
Consistent with the TGN localization, some VAMP-7 may
be retrieved from LEs to participate in another round of
membrane transport. Our data do not rule out the possi-
bility that VAMP-7 also has a role in a distinct TGN trans-
port process and is not used for a single trafficking step.
For example, previous studies of VAMP-7 suggest a role
in transport to the apical membranes in MDCK cells
(Lafont et al., 1999). In general, the morphological and
functional data we present support the idea that different
trafficking steps are mediated by distinct SNARE pro-
teins, consistent with the SNARE hypothesis.
A second criteria necessary for the SNARE hypothesis
to be correct is that the SNAREs pair specifically. The full
spectrum of SNAREs important in trafficking through
the endosomal system to the lysosomes, including those
that might pair with VAMP-7, is not yet fully defined. Re-
cent experiments have shown that many combinations of
SNAREs pair with VAMP-7 to form stable complexes in
vitro (Yang et al., 1999). Syntaxin 1A/SNAP-25, syntaxin
4/SNAP-23, and syntaxin 13/SNAP-29 all form SDS-resis-
tant complexes with VAMP-7; the midpoint temperatures
(
 
T
 
m
 
) of the unfolding transitions for these complexes are
92
 
8
 
C, 88
 
8
 
C, and 85
 
8
 
C, respectively (Yang et al., 1999).
However, relatively small differences in the thermal stabil-
ities of SNARE complexes can result in dramatic dif-
ferences in the abilities of the complexes to mediate
membrane fusion. Therefore, the simple formation of a
complex cannot be taken as an indication of a functional
complex, nor can one easily draw conclusions regarding
specificity based on complex formation in vitro. Given
these caveats, it is the case that syntaxin 1A and SNAP-25
form the most stable complex with VAMP-7 in studies so
far. The 92
 
8
 
C unfolding transition for this complex is more
stable than that for the unfolding transition of syntaxin
1A/SNAP-25 with their known SNARE partner, VAMP-2
(
 
T
 
m
 
, 90
 
8
 
C) (Yang et al., 1999). Therefore, it is unlikely that
information for the specificity of membrane trafficking is
contained within the core complex-forming helical domain
of VAMP-7.
If the core complex formation is not the specificity-
determining event, then why have such a large number of
SNAREs, particularly within the endosomal pathways?
Many SNAREs, including VAMP-7, are considerably
larger than the 70 aa required for fusion complex forma-
tion. In addition, these non–core complex–forming regions
are more highly divergent in aa sequence between the
SNAREs expressed within a species than those sequences
involved in SNARE complex formation. For example, the
cytoplasmic domain of VAMP-7 is 180 aa, and the func-
tion of the NH
 
2
 
-terminal 120 residues of the protein is not
known. Perhaps non–core complex–forming regions of
SNAREs are important for interactions with proteins that
regulate aspects of vesicle targeting specificity. These in-
teractions are likely to involve interactions with Rab pro-
teins and their effectors, and perhaps members of the
sec1p (Hata et al., 1993; Garcia et al., 1994; Pevsner et al.,
1994) family of syntaxin-binding proteins.
The mechanisms whereby SNAREs are localized to dis-
tinct compartments are an additional critical issue for un-
derstanding the organization of membrane compartments.
The aa sequence motifs that direct SNARE localization
are not well understood. It is also not clear for most
SNAREs if particular coat or adaptor proteins are impor-
tant in localizing the proteins to specific vesicles or match-
ing the SNAREs to particular sets of cargo proteins. It is
intriguing that VAMP-7 contains a potential adaptor pro-
tein binding motif, D/EXXXLL (aa 162–167), within the
SNARE coil domain. Perhaps each of the SNAREs will
contain specific sequences that direct binding to particular
adaptor proteins. The small number of aa that are so far
defined to be important for adaptor binding interactions
makes it difficult to understand their significance simply
by inspection of the aa sequences of the SNAREs. Further
experiments are needed to clarify these issues.
Only when we have a complete understanding of the lo-
calizations and protein interactions of all of the membrane
fusion proteins of the VAMP, syntaxin, and SNAP-25
families will we be in a position to fully consider their roles
in specificity. In addition, a full definition of the complex-
ity of SNARE protein function and organization will lead
to a more precise definition of complex membrane traf-
ficking pathways within cells.
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